• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妇科癌症患者化疗引起的恶心:评估问题和个人风险因素评估。

Chemotherapy-induced nausea in a sample of gynaecological cancer patients: assessment issues and personal risk factors evaluation.

机构信息

School of Psychology, Vita-Salute San Raffaele University, Milan, Italy.

Division of Clinical Neurosciences, Health Psychology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

出版信息

Support Care Cancer. 2020 Nov;28(11):5343-5351. doi: 10.1007/s00520-020-05377-1. Epub 2020 Mar 4.

DOI:10.1007/s00520-020-05377-1
PMID:32130508
Abstract

PURPOSE

Chemotherapy-induced nausea (CIN) is a relevant problem for gynaecological cancer patients. The evaluation of CIN is a key aspect in its management, along with the identification of associated risk factors. The objective of the study was to compare different measurements of nausea and to investigate personal risk factors in CIN development.

METHOD

Eighty-one women treated for gynaecological cancers took part. The presence of CIN was evaluated using the MASCC Antiemesis Tool (MAT) and a patient's report to clinicians at the subsequent chemotherapy cycle. Personal risk factors were assessed using the State-Trait Anxiety Inventory and a self-report questionnaire.

RESULTS

The study shows that the agreement between patients' assessment of CIN with MAT and what they referred to clinicians was only moderate for acute nausea (Cohen's Kappa = 0.55; p < 0.001), while good for delayed nausea (Cohen's Kappa = 0.68; p < 0.001). At multiple logistic regression analysis, younger age, anticipatory nausea, patient medium-high expectations of CIN, and parity emerged as risk factors for the development of acute nausea (p = 0.0087, 0.0080, 0.0122 and 0.0021, respectively). Patient medium-high expectations of CIN and being single resulted to be risk factors for delayed nausea (p = 0.0397 and 0.0024, respectively).

CONCLUSIONS

Our findings confirm that personal factors contribute to individual differences in the development of CIN; moreover, we highlight the importance of CIN evaluation by clinicians, underlining the need to use reliable instruments.

摘要

目的

化疗引起的恶心(CIN)是妇科癌症患者的一个相关问题。CIN 的评估是其管理的关键方面,同时还需要确定相关的风险因素。本研究的目的是比较恶心的不同测量方法,并研究 CIN 发展中的个人风险因素。

方法

81 名接受妇科癌症治疗的女性参与了这项研究。使用 MASCC 止吐工具(MAT)和患者在下一个化疗周期向临床医生报告的方式评估 CIN 的发生。使用状态-特质焦虑量表和自我报告问卷评估个人风险因素。

结果

研究表明,患者对 CIN 的评估与 MAT 以及他们向临床医生报告的结果之间的一致性仅在急性恶心方面中度一致(Cohen's Kappa = 0.55;p < 0.001),而在迟发性恶心方面良好(Cohen's Kappa = 0.68;p < 0.001)。在多因素逻辑回归分析中,年龄较小、预期性恶心、患者对 CIN 的中等高度期望以及产次被确定为急性恶心发展的风险因素(p = 0.0087、0.0080、0.0122 和 0.0021)。患者对 CIN 的中等高度期望和单身是迟发性恶心的风险因素(p = 0.0397 和 0.0024)。

结论

我们的研究结果证实,个人因素导致 CIN 发展的个体差异;此外,我们强调了临床医生对 CIN 评估的重要性,强调需要使用可靠的工具。

相似文献

1
Chemotherapy-induced nausea in a sample of gynaecological cancer patients: assessment issues and personal risk factors evaluation.妇科癌症患者化疗引起的恶心:评估问题和个人风险因素评估。
Support Care Cancer. 2020 Nov;28(11):5343-5351. doi: 10.1007/s00520-020-05377-1. Epub 2020 Mar 4.
2
Evaluation of the relation between patient characteristics and the state of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer receiving paclitaxel and carboplatin.评估接受紫杉醇和卡铂化疗的妇科癌症患者的患者特征与化疗引起的恶心和呕吐状况之间的关系。
Arch Gynecol Obstet. 2014 Apr;289(4):859-64. doi: 10.1007/s00404-013-3058-7. Epub 2013 Nov 2.
3
Chemotherapy-induced nausea and vomiting (CINV) with carboplatin plus pemetrexed or carboplatin plus paclitaxel in patients with lung cancer: a propensity score-matched analysis.含培美曲塞或紫杉醇的卡铂化疗方案致肺癌患者恶心呕吐的倾向性评分匹配分析。
BMC Cancer. 2021 Jan 15;21(1):74. doi: 10.1186/s12885-021-07802-y.
4
Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin.阿瑞匹坦预防中度致吐性化疗方案引起的化疗所致恶心和呕吐的疗效:一项针对接受紫杉醇和卡铂治疗的妇科癌症患者的多中心、安慰剂对照、双盲、随机研究。
Int J Clin Oncol. 2016 Jun;21(3):491-7. doi: 10.1007/s10147-015-0928-y. Epub 2015 Dec 10.
5
[Effects of Serum Sodium Concentrations on Nausea and Vomiting after Moderately Emetogenic Chemotherapy].[血清钠浓度对中度致吐性化疗后恶心和呕吐的影响]
Yakugaku Zasshi. 2018;138(8):1095-1101. doi: 10.1248/yakushi.18-00009.
6
Chemotherapy-Induced Nausea and Vomiting in Women With Gynecological Cancer: A Preliminary Single-Center Study Investigating Medical and Psychosocial Risk Factors.妇科癌症女性化疗引起的恶心和呕吐:一项调查医学和社会心理风险因素的单中心初步研究
Cancer Nurs. 2016 Nov/Dec;39(6):E52-E59. doi: 10.1097/NCC.0000000000000342.
7
Evaluation of the validity of chemotherapy-induced nausea and vomiting assessment in outpatients using the Japanese version of the MASCC antiemesis tool.使用日本版MASCC止吐工具评估门诊患者化疗引起的恶心和呕吐评估的有效性。
Support Care Cancer. 2015 Nov;23(11):3331-9. doi: 10.1007/s00520-015-2780-z. Epub 2015 May 24.
8
Evaluation of Combination Antiemetic Therapy on CINV in Patients With Gynecologic Cancer Receiving TC Chemotherapy.联合止吐疗法对接受TC化疗的妇科癌症患者化疗所致恶心呕吐的疗效评估
Anticancer Res. 2019 Jan;39(1):225-230. doi: 10.21873/anticanres.13101.
9
Efficacy of palonosetron plus dexamethasone in preventing chemotherapy-induced nausea and emesis in patients receiving carboplatin-based chemotherapy for gynecologic cancers: a phase II study by the West Japan Gynecologic Oncology Group (WJGOG 131).帕洛诺司琼联合地塞米松预防妇科癌症患者接受卡铂为基础化疗所致恶心呕吐的疗效:一项由日本西部地区妇科肿瘤学组(WJGOG 131)开展的 II 期研究。
J Gynecol Oncol. 2018 Sep;29(5):e77. doi: 10.3802/jgo.2018.29.e77. Epub 2018 May 15.
10
Efficacy of acupuncture in prevention of delayed chemotherapy induced nausea and vomiting in gynecologic cancer patients.针灸预防妇科癌症患者化疗后延迟性恶心和呕吐的疗效。
Gynecol Oncol. 2015 Jan;136(1):82-6. doi: 10.1016/j.ygyno.2014.10.025. Epub 2014 Oct 31.

引用本文的文献

1
Incidence and Risk Factors of Platinum-Based Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis.铂类化疗所致恶心和呕吐的发生率及危险因素:一项系统评价和Meta分析
Curr Oncol. 2025 May 31;32(6):325. doi: 10.3390/curroncol32060325.
2
Risk factors of nausea and vomiting in patients with breast cancer undergoing chemotherapy: A retrospective study.乳腺癌化疗患者恶心呕吐的危险因素:一项回顾性研究。
Medicine (Baltimore). 2025 Jan 17;104(3):e41067. doi: 10.1097/MD.0000000000041067.
3
The Experience of COVID-19 in a Sample of Gynecological Cancer Patients Undergoing Chemotherapy: A Focus on the Psychological Implications.
妇科癌症化疗患者群体的 COVID-19 体验:聚焦心理影响。
Int J Environ Res Public Health. 2023 Feb 21;20(5):3851. doi: 10.3390/ijerph20053851.
4
Socio-demographic and psychological factors associated with quality of life of women undergoing chemotherapy treatment for gynecological cancer.与接受妇科癌症化疗治疗的女性生活质量相关的社会人口学和心理因素。
Support Care Cancer. 2022 Sep;30(9):7333-7339. doi: 10.1007/s00520-022-07162-8. Epub 2022 May 24.